Evaluation of the Safety in the Combination Usage of Cerdelga and Cerezyme in Type III Gaucher Disease Patients and the Efficacy on Soft Tissue Diseases.
Phase of Trial: Phase I
Latest Information Update: 19 May 2018
At a glance
- Drugs Eliglustat (Primary) ; Imiglucerase
- Indications Gaucher's disease type III
- Focus Adverse reactions
- 10 May 2018 New trial record